As a part of The Diagnosis, Classification and Clinical Care of Peripheral T-Cell Lymphoma (DC3-PTCL) educational curriculum, ASCP developed an e-Learning course from the 2014 ASCP Annual Meeting session in Tampa. Through the course, pathologists will have the opportunity to enhance their knowledge of peripheral T-cell Lymphoma diagnosis and management in order to provide better patient outcomes.
Educational Session Title:
The Diagnosis, Classification and Clinical Care of Peripheral T-cell Lymphoma (PTCL)
Educational Session Faculty:
Ahmet Dogan, MD, PhD
Steven M. Horwitz, MD
Eric D. Hsi, MD
Friederike Kreisel, MD, FASCP
Approximately 15 percent of all non-Hodgkin lymphomas in the United States are peripheral T-cell lymphomas (PTCLs), and within this group there are over 20 unique clinicopathological entities. This case-based educational session is designed to examine barriers to early and accurate peripheral T-Cell Lymphoma diagnosis and classification, to highlight the impact of inaccurate diagnosis and classification to clinical management and to provide practical tools and knowledge to address these issues.
This program utilizes the innovative "flipped classroom" model. In addition to the live session, participants will have access to online multimedia cases and CheckPath exercises before and after the session. Participants will also engage directly with the faculty throughout the session.
During the live session at the 2014 ASCP Annual Meeting Tampa an inter-specialty approach was utilized. The pathology faculty collaborated with an oncologist to examine the following peripheral T-cell Lymphoma cases:
- Angioimmunoblastic T-cell lymphoma.
- Anapalstic large cell lymphoma.
- Peripheral T-cell lymphoma, NOS.
- Extranodal T-cell lymphoma.
Upon completion of the educational interventions, participants should be able to:
- Demonstrate accurate PTCL classification/subclassification that reflects expert guidance and takes into account common overlapping or overlooked features.
- Review guidance and expert consensus regarding the range of available tests and their relevance in peripheral T-cell lymphoma differential diagnoses.
- Describe new developments that may affect approaches to the PTCL diagnosis and classification.
- Identify mechanisms and practices within the health care system that can help to minimize suboptimal specimen management and interdisciplinary communication.
- Review key patient and disease characteristics that affect appropriate clinical management of PTCL patients.
The American Society for Clinical Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The ASCP designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT.
Method of Participation
To complete the activity and receive credit, the participant must successfully complete the post-tests for some activities with a score of 80% or higher within 3 attempts. Certificates will be provided on-line.
Funded by an independent education grant from Seattle Genetics